Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine XR versus lithium augmentation for sleep disturbances in SSRI-resistant major depressive disorder
2010-021142-21Phase 3Active
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jul 2010
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in major depressive disorder (MDD) comparing Quetiapine XR augmentation with Lithium augmentation (2 arms). Started Jul 2010; status: active.
02
Drugs
quetiapinelithium carbonate
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2010-021142-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021142-21.